References
- Bonsnes R. W., Taussky H. H. On the colori-metric determination of creatinine by the Jaffe reaction. J. Biol. Chem. 1945; 158: 581
- Brun C. A rapid method for the determination of para-amino-hippuric acid in kidney funct on tests. J. Lab. & Clin. Med. 1951; 37: 955
- Judson W. E., Hollander W. Comparative effects of intravenous and chronic oral 1-Hy-drazinophtalazine on the cardiorenal hemodynamics and the excretion of sodium in hypotensive patients with and without congestive heart failure. Clin. Res. Proc. 1954; 2: 70
- Moyer J. H., Handley C. A., Huggins R. A. Some pharmacodynamic effects of 1-Hydra-zinophtalazine (C—5968) with particular reference to renal function and cardiovascular response. J. Pharmacol. & Exper. Therapy 1951; 103: 368
- Reubi F. C. Renal hyperemia induced in man by a new phtalazine derivative. Proc. Soc. Exper. Biol. & Med. 1950; 73: 102
- Rönnov-Jessen V. Heart failure from retention of salt and water caused by treatment with pentapyrrolidinium birtartrate. Lancet 1955; 263: 127
- Rönnov-Jessen V. Behandling af svér hypertensio arterialis med methoniumforbindelser. Ugeskr. f. Léger 1955; 117: 549
- Yanderkolk K., Dontas A. S., Hoobler S. W. Renal and hypotensive effects of acute and chronic oral treatment with 1-Hydrazinophta-lazine (Apresoline) in hypetension. Am. Heart J. 1954; 48: 95
- Wilkinson E. L., Backman H., Hecht H. H. Cardiovascular and renal adjustments to a hypotensive agent. J. Clin. Investigation 1952; 31: 872
- WerkÖ L., Ek J., Eliasch H., Varnauskas E., Holmgren A., Bucht H. Inverkan av apresoline på circulationen vid hypertens on och mitralisstenos. Nord. Med. 1953; 49: 397